Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.720 | 0.720 | 0.000 |
Shares | 99.280 | 99.280 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.074 | 17.759 |
Price to Book | 5.814 | 3.184 |
Price to Sales | 2.792 | 1.970 |
Price to Cash Flow | 14.804 | 13.276 |
Dividend Yield | 2.792 | 2.931 |
5 Years Earnings Growth | 6.326 | 7.677 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 34.090 | 29.865 |
Consumer Defensive | 18.290 | 14.487 |
Industrials | 18.120 | 15.898 |
Financial Services | 11.460 | 20.078 |
Basic Materials | 10.600 | 8.059 |
Consumer Cyclical | 4.240 | 5.545 |
Technology | 3.200 | 4.143 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 18.16 | 95.56 | +1.51% | |
Roche Holding Participation | CH0012032048 | 11.58 | 231.00 | +1.18% | |
Novartis | CH0012005267 | 10.82 | 92.96 | +1.90% | |
Zurich Insurance Group | CH0011075394 | 6.97 | 473.40 | +0.90% | |
Givaudan | CH0010645932 | 5.80 | 4,233.00 | +0.69% | |
Lonza Group | CH0013841017 | 5.58 | 486.40 | -0.45% | |
ABB | CH0012221716 | 5.14 | 49.40 | +0.16% | |
Sika | CH0418792922 | 4.72 | 272.90 | -1.27% | |
Partners Group | CH0024608827 | 4.41 | 1,208.00 | -0.21% | |
VAT Group | CH0311864901 | 3.81 | 482.70 | -0.52% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 750.49M | 2.63 | -1.47 | 1.89 | ||
Synchrony All Caps CH I | 596.43M | 3.80 | 0.93 | 7.27 | ||
BCV PENSION 40 AP | 524.55M | 4.00 | -0.70 | 3.30 | ||
Synchrony Small Mid Caps CH I | 262.97M | 2.04 | -0.34 | 7.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review